Wilson Sonsini Goodrich & Rosati advised Transcarent on the transaction. Health tech company, Transcarent announced?raising $126 million in Series D funding round led by General Catalyst and...
Transcarent’s $126 Million Series D Funding Round
Pure Lithium’s $15 Million Series A Funding
Wilson Sonsini Goodrich & Rosati advised Pure Lithium on the transaction. Pure Lithium announced it secured $15 million in a Series A financing led by Oxy Low...
Motif Neurotech’s $18.75 Million Series A Financing Round
Wilson Sonsini Goodrich & Rosati advised Motif Neurotech on the transaction. Neurotechnology company, Motif Neurotech announced it raised $18.75 million in oversubscribed Series A financing round. The...
Aqtual’s $16 Million Series A Financing Round
Wilson Sonsini Goodrich & Rosati advised Aqtual on the transaction. Aqtual announced it has completed a $16 million Series A round of financing co-led by Genoa Ventures,...
JURA Bio’s $16.1 Million Financing and Replay Collaboration
Wilson Sonsini Goodrich & Rosati advised JURA Bio on both the financing transaction and the collaboration agreement. JURA Bio announced a research collaboration with Syena, a cell...
Nohbo’s Series A Funding
Wilson Sonsini Goodrich & Rosati advised Nohbo in the transaction. Nohbo announced the completion of its Series A funding round, led by Material Impact Fund. While the...
Delve Bio’s $35 Million Series A Financing Round
Wilson Sonsini Goodrich & Rosati advised Delve Bio in the transaction. Delve Bio announced it has debuted with $35 million in Series A financing led by Perceptive...
PSG’s Growth Investment in 4me
Wilson Sonsini Goodrich & Rosati advised 4me on the transaction. 4me®, a SaaS-based IT Service Management (ITSM) and Enterprise Service Management (ESM) software vendor, has announced...
Fastcase’s Merger with vLex
Wilson Sonsini advised Fastcase on the transaction. Legal technology companies vLex and Fastcase announced that they are merging. Oakley Capital and Bain Capital Credit agreed to...
Elucidata’s $16 Million Series A Fundraising
Wilson Sonsini Goodrich & Rosati advised Elucidata on the transaction. TechBio company Elucidata announced that it has raised $16 million in a Series A fundraising, which...
Rivus Pharmaceuticals’ $132 Million Series B Financing
Wilson Sonsini Goodrich & Rosati advised RA Capital Management on the deal. Rivus Pharmaceuticals, a clinical-stage biopharmaceutical company dedicated to improving cardio-metabolic health, announced the completion...
Arcellx’s $112 Million Public Offering
Wilson Sonsini advised Arcellx on the deal. Arcellx, a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other...